The Medicare GLP-1 Bridge
Medicare’s GLP-1 Bridge is a temporary program that covers certain GLP-1 drugs for eligible people who have Medicare drug coverage. This page sets out what medicare.gov states, and the date we read it.
Pricing data as of .
Who can use this, and what to watch for
Every point below comes from the same data file that drives the price table, so it cannot drift from the figures on this page.
You cannot use this pathway if
- Medicare states that you are not eligible for this program if you already get GLP-1 drugs covered through your Medicare Part D plan, or if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. Your Part D plan might cover your GLP-1 instead. Confirm your own position with Medicare.
You need
- This pathway is available only to Medicare beneficiaries.
Worth knowing
- Requires a valid prescription from a licensed healthcare provider.
- Mounjaro is approved for type 2 diabetes, not for weight management. Coverage and program eligibility follow the diabetes indication.
- Ozempic is approved for type 2 diabetes, not for weight management. Coverage and program eligibility follow the diabetes indication.
- This programme requires a BMI of 35 or higher, or a BMI of 30 or higher with diastolic heart failure, uncontrolled high blood pressure, or chronic kidney disease at stage 3a or higher, or a BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms. It covers Foundayo tablets, Wegovy injection and tablets, and the Zepbound KwikPen specifically rather than Zepbound vials, and it is available nationwide. Read from medicare.gov on 2026-10-28.
- Medicaid GLP-1 coverage is state-by-state. A federal program for 2026 negotiates terms on behalf of state Medicaid agencies, but participation is voluntary and what you pay depends on your own state. There is no national Medicaid price for these medications and this site does not publish one.
- The programme covers the Zepbound KwikPen only. The page states: "Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens)." If you have been prescribed single-dose vials or a pen, this pathway does not apply to you. Check which presentation your prescription is for before you count on it.
- The page states that you are not eligible if you already get GLP-1 drugs covered through your Medicare Part D plan, or if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease.
- The page states that your prior authorization is valid, including for refills and dose changes, through December 31, 2027, unless you change GLP-1 medicines.
- The page states that TrumpRx and other types of discount cards are not considered creditable coverage: what you pay for drugs this way does not count toward your Medicare deductible or out-of-pocket maximum.
- The programme covers Wegovy injection. The page lists it as "Wegovy® (injection or tablet)".
- The programme covers Wegovy tablets. The page lists it as "Wegovy® (injection or tablet)".
- The programme covers Foundayo tablets. The page lists it as "Foundayo® (tablet)".
What Medicare states
Medicare states that the program covers Foundayo tablets, Wegovy injection and tablets, and the Zepbound KwikPen. It does not cover single-dose Zepbound vials or pens. To qualify you must be 18 or older and meet a body mass index requirement, which is lower if you have certain health conditions. The cost is a fixed monthly copayment, shown below with the date we read it.
How we apply it
Our eligibility check follows the criteria and exclusions on medicare.gov, including the exclusion for people whose Medicare drug plan already covers their GLP-1 drug. If you are close to a threshold or unsure which form of the drug you were prescribed, confirm with Medicare at 1-800-MEDICARE before you count on this pathway.
If you are on Medicare, the savings card is not an option
Manufacturer copay and savings cards exclude anyone enrolled in a federal healthcare program. Our tool removes that pathway entirely for Medicare and Medicaid beneficiaries rather than showing a low copay you cannot claim. What remains available is this program, standard Part D coverage where your plan covers the indication, and cash-pay direct programs.
Questions people ask about The Medicare GLP-1 Bridge
Who is eligible for the Medicare GLP-1 Bridge?
Medicare states that the program gives eligible beneficiaries a fixed monthly copayment for a covered GLP-1, with a BMI threshold and a further route in at a lower BMI. You are not eligible if you already get GLP-1 drugs covered through your Part D plan, or if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. Confirm your own eligibility with Medicare directly.
Is the Medicare GLP-1 Bridge price confirmed?
Yes. The cost is a fixed monthly copayment, shown below with the date we read it.
Can I use a manufacturer savings card on Medicare?
No. Manufacturer copay and savings cards exclude anyone enrolled in a federal healthcare program. What remains available is this program, standard Part D coverage where your plan covers the indication, and cash-pay direct programs.
Every figure we hold for this pathway
| Medication | Pathway | Dose or tier | Monthly | Confidence | Source type | Verified | Source |
|---|---|---|---|---|---|---|---|
| Zepbound | Medicare GLP-1 Bridge | any | $50 | Confirmed | Primary, government | 2026-10-29 | Open |
| Wegovy | Medicare GLP-1 Bridge | any | $50 | Confirmed | Primary, government | 2026-10-29 | Open |
| Wegovy tablets | Medicare GLP-1 Bridge | any | $50 | Confirmed | Primary, government | 2026-10-29 | Open |
| Foundayo | Medicare GLP-1 Bridge | any | $50 | Confirmed | Primary, government | 2026-10-29 | Open |
Compare it against everything else
A single pathway in isolation cannot tell you whether it is your cheapest option. Use the tool to rank this pathway against every other one for your medication, your insurance situation and your dose.